advertisement

Topcon

Abstract #5829 Published in IGR 2-1

Carbonic anhydrase inhibitors (Part 78): synthesis of water-soluble sulfonamides incorporating beta-alanyl moieties, possessing long-lasting intraocular pressure lowering properties via the topical route

Supuran CT; Briganti F; Menabuoni L; Mincione G; Mincione F; Scozzafava A
European Journal of Medicinal Chemistry 2000; 35: 309-321


The reaction of 26 aromatic/heterocyclic sulfonamides containing amino, imino, hydrazino or hydroxyl groups with N-tert-butyloxycarbonyl-beta-alanine (Boc-beta-ala; Boc = t-butoxycarbonyl) in the presence of carbodimide derivatives afforded, after removal of the protecting group, a series of water-soluble compounds (salts of strong acids, such as hydrochloric, trifluoroacetic or trifluoromethane sulfonic). The new derivatives were assayed as inhibitors of the zinc enzyme carbonic anhydrase (CA), and more precisely of three of its isozymes, CA I, II (cytosolic forms) and IV (membrane-bound form), involved in important physiological processes. Good inhibition was observed against all three isozymes, but especially against CA II and CA IV (in the nanomolar range), the two isozymes known to play a critical role in aqueous humor secretion within the ciliary processes of the eye. Some of the best inhibitors synthesized were applied as 2% aqueous solutions into the eyes of normotensive or glaucomatous albino rabbits, and strong and long-lasting intraocular pressure (IOP) lowering was observed in many of them. Thus, the amino acyl groups conferring water solubility to these sulfonamide CA inhibitors, coupled with their strong enzyme inhibitory properties and balanced lipid solubility, seem to be the key factors for obtaining compounds with effective topical antiglaucoma activity.

Dr. C.T. Supuran, Universita degli Studi, Lab. Chim. Inorganica/Bioinorganica, Via Gino Capponi 7, I-50121 Florence, Italy


Classification:

11.5.2 Topical (Part of: 11 Medical treatment > 11.5 Carbonic anhydrase inhibitors)



Issue 2-1

Change Issue


advertisement

Oculus